medigraphic.com

2009, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2009; 47 (5)

Uncontrolled Chronic Glycaemia in Diabetic Patients with Neoplasm Increases the Risk of Early Surgical Complications

González-Ávila G, Medrano-Ortiz de Zárate ME, Domínguez-Rojo S

Language: Spanish
References: 19
Page: 531-538
PDF size: 43.23 Kb.


ABSTRACT

Background: the effect of uncontrolled chronic glycemia (UCG) in the diabetic patient with a neoplasm (DPN) has not been evaluated during the early postoperative period. Our objective was to determine the frequency of early surgical complications in the DPN with UCG.
Methods: a cohort of 184 consecutive diabetic patients who had a histological malignant diagnosis were studied; they were matched with 184 nondiabetic controls by age, gender, neoplasm type and surgery, those who received chemotherapy or irradiation 30 days before surgery were excluded. Fasting blood glucose, HbA1c, presence of diabetic complications and co-morbidity before surgery; type of surgery and posoperative early morbidity and mortality were measured.
Results: the DPN with UCG had a higher frequency of surgical posoperative complications than their controls. The presence of co-morbidity (p ‹ 0.011) and HbA1c › 6.5 % (p ‹ 0.011) were independent and ominous significant predictors.
Conclusions: preoperative UCG increases the risk of early surgical complications in DPN.


REFERENCES

  1. Strickler HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Buró RD, et al. The relation of type 2 diabetes and cancer. Diabetes Technol Ther 2001;3(2):263-274.

  2. Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL, et al. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 2005;92(11):2070- 2075.

  3. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004;159(12):1160-1167.

  4. Yang YX, Hennessy S, Lewis JD. Type 2 diabetes mellitus and the risk of colorrectal cancer. Clin Gastroenterol Hepatol 2005;3(6):587-594.

  5. Coursin DB, Connery LE, Ketzler JT. Perioperative diabetic and hyperglycemic management issues. Crit Care Med 2004;32(4 Suppl):S116-S125.

  6. Folsom AR, Anderson KE, Sweeney C, Jacobs DR Jr. Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol 2004;94(3):740-745.

  7. Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 2002;6(1):88-94.

  8. Batty GD, Shipley MJ, Marmot M, Smith GD. Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control 2004;15(9):873-881.

  9. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20(7):1183-1197.

  10. Tapp RJ, Tikellis G, Wong TY, Harper C, Zimmet PZ, Shaw JE. Longitudinal association of glucose metabolism with retinopathy; results from the Australian Diabetes Obesity and Lifestyle (AusDiab) Study. Diabetes Care 2008;31(7):1349-1354.

  11. Wong TY, Liew G, Tapp RJ, Schmidt MI, Wang JJ, Mitchell P, et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes three population based cross-sectional studies. Lancet 2008;371(9614):736-743.

  12. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications ot type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321 (7258):405-412.

  13. Richardson LC, Pollack LA. Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2005;2(1):48-53.

  14. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003;21(3):433-440.

  15. United Kingdom Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837-853.

  16. Finney SJ, Zeekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003;290(15):2041-2047.

  17. Yusuf S. Intensive insulin-glucose infusion regimens with long-term or standard glucose control did not differ for reducing mortality in type 2 diabetes mellitus and MI. ACP J Club 2005;143(2):43.

  18. Glucose control reduces ICU stay and mortality. Perform Improv Advis 2005;9(1):4-6, 1. [No authors listed]

  19. International Expert Committee. International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32 (7):1327-1334.




2020     |     www.medigraphic.com